Detection of Anti-Leishmania(Leishmania)chagasiImmunoglobulin G by Flow Cytometry for Cure Assessment following Chemotherapeutic Treatment of American Visceral Leishmaniasis
- 1 May 2007
- journal article
- clinical trial
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 14 (5) , 569-576
Abstract
The residual serological reactivity observed in patients cured of visceral leishmaniasis (VL) represents the major factor underlying the low efficiency of most anti-Leishmaniaserological approaches to assess posttherapeutic cure in VL. Herein, we have described a detuned flow cytometry-based methodology to detect anti-live (FC-ALPA-immunoglobulin G [IgG]) and anti-fixed (FC-AFPA-IgG)L. chagasipromastigote IgG, along the titration curve (1:2,000 to 1:128,000), as a tool to assess late (12 months after treatment [12 mAT]) and early (2 and 6 mAT) posttherapeutic cure of pediatric American visceral leishmaniasis. Reactivities were reported as the percentage of positive fluorescent parasite (PPFP), using a PPFP of 50% as a cutoff to segregate positive and negative results. Our data demonstrated that both FC-ALPA-IgG at 1:4,000 and FC-ALPA-IgG at 1:32,000 are useful for late cure assessment in VL, with 100% specificity and outstanding likelihood ratio indices. Cure assessment at 6 mAT also showed promising performance indices, identifying 81% and 71.4% of the treated patients with negative results. However, new interpretation parameters were necessary to monitor cure at 2 mAT. We then introduced the differential PPFP (ΔPPFP) of 25% as a new cutoff for early cure assessment at specific serum dilutions to analyze IgG reactivity by FC-ALPA-IgG and FC-AFPA-IgG. Our data demonstrated that at 2 mAT, ΔPPFP was >25% in 60% and 57.1% of treated patients, whereas at 6 mAT, a ΔPPFP of >25% was observed in 100% and 95.2% of samples assayed by FC-ALPA-IgG and FC-AFPA-IgG, respectively. Together, our findings showed the potential of both FC-ALPA-IgG and FC-AFPA-IgG regarding their applicability to detect differential serological reactivity and further contribution to posttherapeutic cure assessment in VL.Keywords
This publication has 19 references indexed in Scilit:
- Host serological response to Helicobacter pylori after successful eradication: long-term follow-up in patients with cured and persistent infectionAlimentary Pharmacology & Therapeutics, 2007
- Clinical value of anti‐live Leishmania (Viannia) braziliensis immunoglobulin G subclasses, detected by flow cytometry, for diagnosing active localized cutaneous leishmaniasisTropical Medicine & International Health, 2006
- Recombinant Leishmania Antigens for Serodiagnosis of Visceral LeishmaniasisClinical and Vaccine Immunology, 2005
- Antibodies against a Leishmania infantum peroxiredoxin as a possible marker for diagnosis of visceral leishmaniasis and for monitoring the efficacy of treatmentImmunology Letters, 2005
- Characterization of Immunoglobulin G and Its Subclass Response to Indian Kala-Azar Infection before and after ChemotherapyInfection and Immunity, 2004
- Anticorpos antipromastigotas vivas de Leishmania (Viannia) braziliensis, detectados pela citometria de fluxo, para identificação da infecção ativa na leishmaniose tegumentar americanaRevista da Sociedade Brasileira de Medicina Tropical, 2002
- Enzyme-Linked Immunosorbent Assay for Recombinant K39 Antigen in Diagnosis and Prognosis of Indian Visceral LeishmaniasisClinical and Diagnostic Laboratory Immunology, 2001
- LeishmaniasisClinics in Dermatology, 1996
- Clinical Spectrum of LeishmaniasisClinical Infectious Diseases, 1996
- Measuring the Accuracy of Diagnostic SystemsScience, 1988